SEARCH RESULT

Thursday, November 27, 2025
Boehringer Ingelheim gets positive opinions from European Medicines Agency for marketing of bird flu vaccines
Boehringer Ingelheim, a global leader in preventive medicines for livestock, obtained positive opinions by the European Medicines Agency (EMA) recommending the granting of marketing authorisations under exceptional circumstances for its avi ...
Tuesday, September 10, 2024
EU not close to getting vaccine against ASF as Italy, Germany, and Poland see disease's resurgence
The European Commission has warned that the European Union is not close to finding a vaccine against African swine disease (ASF).
Tuesday, February 13, 2024
European project VAX4ASF to develop next-generation vaccine against ASF
The European initiative known as VAX4ASF (New Technologies for African Swine Fever) has commenced with the ambitious goal of creating an advanced vaccine against the African swine fever (ASF) virus, aiming to combat the disease on a global ...
Thursday, November 16, 2023
Australian researchers collaborate with MBF Therapeutics to evaluate ASF vaccine candidate
Australian researchers at the CSIRO Australian Centre for Disease Preparedness (ACDP) have joined forces with United States company MBF Therapeutics to assess the effectiveness of an African swine fever (ASF) vaccine candidate, Farm Journal ...
Thursday, October 26, 2023
European agriculture ministers urge pharma companies to develop bluetongue vaccine
Agriculture ministers from the Netherlands, Germany, and Belgium have jointly called on pharmaceutical companies to expedite the development of a new vaccine as they grapple with an ongoing outbreak of bluetongue disease, Euractiv reported.
Tuesday, April 13, 2021
Boehringer Ingelheim introduces new-generation Marek's disease vaccine in EU and UK
Boehringer Ingelheim announced that it has introduced PREVEXXION® RN in the European Union and the United Kingdom. It is the first innovation in the Marek category of vaccines in over 40 years.
Wednesday, March 3, 2021
Elanco introduces vaccine for bovine pneumonia and BRD
Elanco Animal Health Incorporated has introduced NUPLURA PH+, providing fast, smooth and flexible protection against bovine respiratory disease (BRD), Bovine Veterinarian reported.
Thursday, January 21, 2021
Merck introduces 5-in-1 intranasal vaccine for cattle pneumonia
Merck Animal Health has announced that Bovilis® Nasalgen® 3-PMH is now available to veterinarians and cattle producers to protect cattle from five of the most common pneumonia-causing viral and bacterial pathogens, Hoard's Dairyman reported ...
Tuesday, November 10, 2020
Ceva strengthens preventative health strategy with new European reference for producing autogenous vaccines
Ceva Santé Animale has increased three-fold its production capacity for bacterial autogenous vaccines - primarily, for pigs and poultry - at its French plant, the company said in late-September.
Tuesday, July 28, 2020
Cattle disease vaccine from EU arrives in Taiwan county
EU's donation of 10,000 vaccine doses to combat lumpy skin disease in cattle arrived in Taiwan's outlying Kinmen County on Wednesday evening, July 22, Focus Taiwan reported.
Monday, January 13, 2020
MBF Therapeutics, Smithfield Foods ink agreement to develop new swine vaccines
No Abstract
Tuesday, October 1, 2019
Boehringer Ingelheim obtains European authorisation for porcine parvovirus vaccine
No Abstract
Thursday, May 9, 2013
EU approves IDT's new oedema vaccine
No Abstract
Friday, October 5, 2012
Kyrgyzstan, Uzbekistan livestock vaccines contain pseudorabies virus
No Abstract
Tuesday, April 17, 2012
Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains
Mycoplasma hyopneumoniae is the primary cause of enzootic pneumonia in pigs. The study compared the protective efficacy of four bacterins against challenge infection with a highly virulent field strain of M. hyopneumoniae.

Follow Us

FacebookTwitterLinkedIn